These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1100 related items for PubMed ID: 12970094

  • 1. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [Abstract] [Full Text] [Related]

  • 2. Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury.
    Genovese T, Cuzzocrea S, Di Paola R, Mazzon E, Mastruzzo C, Catalano P, Sortino M, Crimi N, Caputi AP, Thiemermann C, Vancheri C.
    Eur Respir J; 2005 Feb; 25(2):225-34. PubMed ID: 15684285
    [Abstract] [Full Text] [Related]

  • 3. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock.
    Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muià C, Caputi AP.
    Shock; 2004 Oct; 22(4):340-6. PubMed ID: 15377889
    [Abstract] [Full Text] [Related]

  • 4. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B, Hake PW, Mangeshkar P, O'Connor M, Burroughs TJ, Piraino G, Denenberg A, Wong HR.
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [Abstract] [Full Text] [Related]

  • 5. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C.
    FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
    [Abstract] [Full Text] [Related]

  • 6. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
    Genovese T, Esposito E, Mazzon E, Di Paola R, Muià C, Meli R, Bramanti P, Cuzzocrea S.
    Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
    [Abstract] [Full Text] [Related]

  • 7. Green tea polyphenol extract attenuates ischemia/reperfusion injury of the gut.
    Muià C, Mazzon E, Di Paola R, Genovese T, Menegazzi M, Caputi AP, Suzuki H, Cuzzocrea S.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):364-74. PubMed ID: 15997392
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R.
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [Abstract] [Full Text] [Related]

  • 9. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE, Gould H, Harris T, Bonacci JV, Stewart AG.
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [Abstract] [Full Text] [Related]

  • 10. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY.
    Arthritis Res Ther; 2005 Feb; 7(6):R1325-37. PubMed ID: 16277686
    [Abstract] [Full Text] [Related]

  • 11. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P, Thalhammer T, Jäger W, Aust S, Steiner G, Ensinger C, Obrist P.
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
    Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C.
    Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
    [Abstract] [Full Text] [Related]

  • 13. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel NS, Di Paola R, Ialenti A, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
    Eur J Pharmacol; 2004 Jan 01; 483(1):79-93. PubMed ID: 14709329
    [Abstract] [Full Text] [Related]

  • 14. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
    Migita H, Morser J.
    Arterioscler Thromb Vasc Biol; 2005 Apr 01; 25(4):710-6. PubMed ID: 15662020
    [Abstract] [Full Text] [Related]

  • 15. A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats.
    Takagi T, Naito Y, Ichikawa H, Tomatsuri N, Katada K, Isozaki Y, Kuroda M, Kokura S, Yoshida N, Yoshikawa T.
    Redox Rep; 2004 Apr 01; 9(6):376-81. PubMed ID: 15720836
    [Abstract] [Full Text] [Related]

  • 16. The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock.
    Abdelrahman M, Collin M, Thiemermann C.
    Shock; 2004 Dec 01; 22(6):555-61. PubMed ID: 15545828
    [Abstract] [Full Text] [Related]

  • 17. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun 01; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ, Park KS, Chung SY, Sheen YY, Moon DC, Song YS, Kim KS, Song S, Yun YP, Lee MK, Oh KW, Yoon DY, Hong JT.
    J Pharmacol Exp Ther; 2003 Nov 01; 307(2):505-17. PubMed ID: 12966153
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects.
    Calabrò P, Samudio I, Safe SH, Willerson JT, Yeh ET.
    J Vasc Res; 2005 Nov 01; 42(6):509-16. PubMed ID: 16155367
    [Abstract] [Full Text] [Related]

  • 20. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K, Dworzanski T, Korolczuk A, Piasecki R, Slomka M, Madro A, Fornal R.
    J Physiol Pharmacol; 2011 Jun 01; 62(3):347-56. PubMed ID: 21893696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.